Cours Med Biogene Inc Toronto S.E.
Actions
MBI
CA58402B1076
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 130 k 178 k 117 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 0 | Résultat net 2023 | - 0 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 407 556,37 365,12 | Trésorerie nette 2023 | 713 974,67 639,64 | VE / CA 2023 | - |
PER 2022 |
-4,96
x | PER 2023 |
-2,24
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 45,35% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/09/14 |
Ibrahim Ghobrial
DFI | Director of Finance/CFO | - | 05/09/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Toby Weir-Jones
BRD | Director/Board Member | - | 05/09/14 |
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/09/14 |
David Diebolt
BRD | Director/Board Member | - | 05/09/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
-44,08% | 7,63 Md | |
+8,98% | 3,61 Md | |
+3,94% | 2,36 Md | |
-24,94% | 1,86 Md | |
-17,38% | 1,74 Md | |
+4,89% | 913 M | |
+21,75% | 763 M | |
-11,57% | 678 M | |
-30,82% | 500 M |